New Webcasts

Emerging Strategies in the Immune Checkpoint Inhibitors (ICIs) and the Synergistic Effect of Antibody-Drug Conjugate in Combination with ICIs for Urothelial Carcinoma
Released on 4/18/2023
Expires on 4/18/2024

Sustained-Release Drug Delivery System in the Management of Glaucoma
Released on 4/7/2023
Expires on 4/72024

Glaucoma: Sustained-release Drug Delivery System, Topical Agents, and Emerging 3D Visualization Technologies
Released on 3/1/2023
Expires on 3/12024

Hepatocellular Carcinoma: Immune Checkpoint Inhibitors, Multi-Targeted Tyrosine Kinase Inhibitors and the Combination Thereof
Released on 2/9/2023
Expires on 2/9/2024

New Strategies in the Diagnosis and Treatment of Follicular Lymphoma: 2022 ASH Update
Released on 12/30/2023
Expires on 12/30/2024

Advances in Symptom Burden, Risk Stratification, and Treatment of Myelofibrosis
Released on 1/25/2023
Expires on 1/25/2024

New Strategies in the Treatment of Follicular Lymphoma: 2022 ASH Update
Released on 12/30/22
Expires on 12/30/23

New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases
Released on 12/14/22
Expires on 12/14/23

Emerging Strategies in the Treatment of Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Carcinoma
Released on 12/8/22
Expires on 12/8/23

Ovarian Cancer: Mutations, Biomarkers, and Treatment with PARP Inhibitors and Immunotherapy
Released on 10/21/22
Expires on 10/21/23

Immune Checkpoint and BRAF/MEK Inhibitor- directed Therapies for Advanced Melanoma
Released on 9/14/22
Expires on 9/14/23

Emerging Treatment Options for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Released on 6/24/22
Expires on 6/24/23

Emerging Treatment Options for Pustular Psoriasis
Released on 5/31/22
Expires on 5/31/23

Current and New Biomarkers and Targeted Therapy Options for Gastric and Gastroesophageal Junction Cancers
Released on 5/20/22
Expires on 5/20/23

Emerging Strategies in the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis (ALS)
Released on 5/2/22
Expires on 5/2/23

Current and Emerging Treatment Options for Multiple Myeloma
Released on 4/7/22
Expires on 4/7/23

Novel Therapies for Chronic Rhinosinusitis with Nasal Polyps
Released on 3/25/22
Expires on 3/25/23

Novel Treatment Options for Multiple Myeloma
Released on 3/24/22
Expires on 3/24/23

New and Emerging Treatment Options for Hematological Malignancies
Released on 12/30/21
Expires on 12/30/22

Advances in Biological Therapies for Atopic Dermatitis in Adults and Children
Released on 12/10/21
Expires on 12/10/22

Evolving Strategies in the Treatment of HER2-positive Metastatic Breast Cancer with Antibody-Drug Conjugates and Tyrosine Kinase Inhibitors
Released on 12/8/21
Expires on 12/8/22

Emerging Strategies in the Management of Genitourinary Cancers
Released on 11/22/21
Expires on 11/22/22

Biosimilars: Implications for Clinical Practice in Inflammatory Bowel Diseases
Released on 11/18/21
Expires on 11/18/22

Novel Therapies for Metastatic Castrate Resistant Prostate Cancer with PARP-Inhibitors and BITE Immunotherapy
Released on 11/8/21
Expires on 11/8/2

Advances in the Diagnosis and Treatment of Eosinophilic Esophagitis
Released on 10/21/21
Expires on 10/21/22

Emerging Treatment Options for BRAF-mutant Colorectal Cancer
Released on 9/9/21
Expires on 9/9/22

Novel Treatment and Management Options for Chronic Idiopathic Constipation
Released on 7/23/21
Expires on 7/23/22

New Paradigms in the Treatment and Management of Neovascular Age-related Macular Degeneration (nAMD)
Released on 6/29/21
Expires on 6/29/22

New Paradigms for Treatment and Management of Retinal Vein Occlusion (RVO)
Released on 6/14/21
Expires on 6/14/22

Changing Landscape of Treatment for Acute Lymphoblastic Leukemia
Released on 5/26/21
Expires on 5/26/22

New Paradigms in the Treatment and Management of Age-related Macular Degeneration (AMD)
Released on 4/30/21
Expires on 4/30/22

Biosimilars: Implications for Clinical Practice in Hematological Malignancies & Supportive Care
Released on 4/30/21
Expires on 4/30/22

Update on the Immune Checkpoint Inhibitor and Combination Targeted Therapies for Hepatocellular Carcinoma
Released on 3/18/20
Expires on 3/18/21

New Paradigms in the Biological Therapies for Atopic Dermatitis
Released on 3/10/20
Expires on 3/10/21

Changing Landscape of NSCLC with Targeted Therapies and Immunotherapy
Released on 12/08/20
Expires on 12/08/21

Advances in the Treatment of dMMR/MSI-H Colorectal Cancer with Immunotherapy
Released on 12/05/20
Expires on 12/05/21

Emerging Strategies in the Management of Chronic Fibrosing ILD Patients Who Have Contracted COVID-19
Released on 10/28/20
Expires on 10/28/21

Changing Landscape of Treatment Options for Multiple Myeloma
Released on 10/5/20
Expires on 10/5/21

Changing Landscape of Treatment Options for Hematological Malignancies
Released on 9/28/20
Expires on 9/28/21

Current and Emerging Treatment Options for Renal Cell Carcinoma
Released on 10/10/20
Expires on 10/18/21

Current and Emerging Treatment Options for Lung Cancer and Head & Neck Cancer
Released on 7/22/21
Expires on 7/30/21

Current and Emerging Treatment Options for Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Carcinoma)
Released on 6/15/20
Expires on 6/15/21

Changing Landscape of Treatment Options for Metastatic Urothelial Carcinoma
Released on 5/22/20
Expires on 5/22/21

New Paradigms in the Treatment of Relapsed Multiple Myeloma 
Released on 5/3/20
Expires on 5/3/21

New Paradigms in the Treatment Options for Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML): European Perspective
Released on 4/28/20
Expires on 4/28/21

Current and Emerging Treatment Options for Lung Cancer and Head & Neck Carcinoma
Released on 12/30/19
Expires on 12/30/20

View All Webcasts